Theresa Tribble
About Theresa Tribble
Theresa Tribble is the Chief Executive Officer of Droplet Biosciences, Inc., with extensive experience in healthcare and life sciences. She has held various leadership roles, including positions at Akita Biosciences, EverlyWell, and The Engine.
Work at Droplet
Theresa Tribble serves as the Chief Executive Officer of Droplet Biosciences, Inc., a position she has held since 2021. Under her leadership, the company focuses on innovative solutions in the healthcare and life sciences sectors. Her role involves strategic decision-making and guiding the company's vision to address significant challenges in these fields.
Education and Expertise
Theresa Tribble holds a Master of Business Administration (MBA) from Harvard Business School. She also earned a Bachelor of Arts (BA) in Political Science and English from Wellesley College. Her educational background supports her expertise in business strategy and management, particularly within the healthcare sector.
Background
Theresa Tribble has a diverse professional background with extensive experience in the healthcare and life sciences industries. She worked at Putnam Associates from 2003 to 2007, where she held roles as Associate and Senior Associate. She has also contributed to various organizations, including The Engine, EverlyWell, and Akita Biosciences, showcasing her commitment to advancing healthcare solutions.
Achievements
During her tenure at Akita Biosciences, Theresa Tribble led the development of a proprietary drug delivery platform that enhances mucosal absorption and residence time for various molecules and biologics. She also pioneered a once-daily nasal spray aimed at reducing the risk of respiratory infections, including Influenza A, Influenza B, SARS-CoV-2, and others, demonstrating her impact in the healthcare field.
Professional Roles
In addition to her role at Droplet Biosciences, Theresa Tribble has served in various capacities across multiple organizations. She was a Venture Partner and Operating Partner at The Engine, and held the position of Chief Business Officer at EverlyWell. She is also involved as an Advisor at Akita Biosciences and BigHat Biosciences, reflecting her ongoing engagement in the life sciences sector.